Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Gasdermin D inhibition confers antineutrophil-mediated cardioprotection in acute myocardial infarction
Kai Jiang, Zizhuo Tu, Kun Chen, Yue Xu, Feng Chen, Sheng Xu, Tingting Shi, Jie Qian, Lan Shen, John Hwa, Dandan Wang, Yaozu Xiang
Kai Jiang, Zizhuo Tu, Kun Chen, Yue Xu, Feng Chen, Sheng Xu, Tingting Shi, Jie Qian, Lan Shen, John Hwa, Dandan Wang, Yaozu Xiang
View: Text | PDF
Research Article Cardiology

Gasdermin D inhibition confers antineutrophil-mediated cardioprotection in acute myocardial infarction

  • Text
  • PDF
Abstract

Acute myocardial infarction (AMI) induces blood leukocytosis, which correlates inversely with patient survival. The molecular mechanisms leading to leukocytosis in the infarcted heart remain poorly understood. Using an AMI mouse model, we identified gasdermin D (GSDMD) in activated leukocytes early in AMI. We demonstrated that GSDMD is required for enhanced early mobilization of neutrophils to the infarcted heart. Loss of GSDMD resulted in attenuated IL-1β release from neutrophils and subsequent decreased neutrophils and monocytes in the infarcted heart. Knockout of GSDMD in mice significantly reduced infarct size, improved cardiac function, and increased post-AMI survival. Through a series of bone marrow transplantation studies and leukocyte depletion experiments, we further clarified that excessive bone marrow–derived and GSDMD-dependent early neutrophil production and mobilization (24 hours after AMI) contributed to the detrimental immunopathology after AMI. Pharmacological inhibition of GSDMD also conferred cardioprotection after AMI through a reduction in scar size and enhancement of heart function. Our study provides mechanistic insights into molecular regulation of neutrophil generation and mobilization after AMI, and supports GSDMD as a new target for improved ventricular remodeling and reduced heart failure after AMI.

Authors

Kai Jiang, Zizhuo Tu, Kun Chen, Yue Xu, Feng Chen, Sheng Xu, Tingting Shi, Jie Qian, Lan Shen, John Hwa, Dandan Wang, Yaozu Xiang

×

Figure 4

GSDMD is essential for recruitment of neutrophils/monocytes to the infarcted heart.

Options: View larger image (or click on image) Download as PowerPoint
GSDMD is essential for recruitment of neutrophils/monocytes to the infar...
(A and B) Flow cytometric analysis and quantification of Cd11b+Ly6G+ neutrophils and Cd11b+Ly6C+ monocytes in the heart (left), blood (middle), or BM (right) from WT or Gsdmd−/− mice 72 hours after AMI (n = 7–15). (C) Immunofluorescence imaging and magnification for MPO (red), TUNEL (green), and DAPI (blue) on heart sections from WT or Gsdmd−/− mice 24 hours after AMI. Scale bar: 20 μm. (D and E) Quantification of ratios of MPO+ or TUNEL+ cells of heart sections from WT or Gsdmd−/− mice. Each value was averaged from the values of 7 fields of view from the same mouse (n = 3 per group). (F) Immunofluorescence imaging of heart sections from WT or Gsdmd−/− mice 3 days after AMI showing α-actinin (red), CD68 (green), and DAPI (blue). Representative fields of remote zone, border zone, and infarct zone are presented. Scale bar: 20 μm. (G and H) Quantification of CD68+ area proportion in the field of view in remote zone (G) and border and infarct zones (H) of heart sections from WT or Gsdmd−/− mice. Each value was averaged from the values of 5 fields of view from the same mouse (n = 3 per group). Data are presented as mean ± SD. *P < 0.05; ****P < 0.0001 by multiple 2-tailed Student’s t test (B) or unpaired, 2-tailed Student’s t test (D, E, G, and H). NS, not significant.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts